On June 27, 2024, the Supreme Court of Canada dismissed the applications for leave to appeal in Apotex Inc. v. Janssen Inc. et al., 2024 FCA 9 and Pharmascience Inc. v. Janssen Inc. et al., 2024 FCA 10, both Federal Court of Appeal decisions pertaining to inducing infringement of a patented dosing regimen. We published […]
The Federal Court (per St-Louis J.) held that the asserted claims of three patents owned by Nordik Blades (collectively, the “Nordik Patents”) are invalid on the basis of obviousness. However, the Court found that the asserted claims are not overbroad and the Nordik Patents are not void under section 53 of the Patent Act. The
Snowplow Patents are Snowed Under due to Federal Court Findings of Obviousness Read More »
On December 18, 2023, the Government of Canada announced the creation of the Canadian Drug Agency (“CDA”) built from CADTH in partnership with provinces and territories. The implementation of CDA is supported by an investment of $89.5 million over 5 years. The creation of the CDA has been in the works for many years.
Announcement of a new Canadian Drug Agency by the Government of Canada Read More »
We are very excited to announce that prominent Canadian lawyer, Dino Clarizio, has joined the partnership, and that the firm will now be known as Markwell Clarizio LLP. Dino has practised at leading national firms and boutiques for more than thirty years. He is a registered patent agent in Canada and the U.S. as well
Markwell LLP expands and rebrands as Markwell Clarizio LLP Read More »
On April 6, 2023, Chambers and Partners published its 2023 Life Sciences Global Practice Guide. Markwell LLP is very pleased to have been invited to be the exclusive author of the Canadian sections of this comprehensive practice guide which is considered the “definitive global law guide offering comparative analysis from top ranked lawyers”. In the
Markwell LLP is a Contributor to the Chambers LIFE SCIENCES 2023 Global Practice Guide Read More »